Critical roles of capillary endothelial cells for alveolar remodeling in nonspecific and usual interstitial pneumonias

Journal of Nippon Medical School

Volumn 73, Issue 4, 2006, Pages 203-213

  Tachihara, Akitoshi ^a   Jin, Enjing ^a   Matsuoka, Toshiaki ^a   Ghazizadeh, Mohammad ^a   Yoshino, Shinichi ^a   Takemura, Tamiko ^b   Travis, William D ^c   Kawanami, Oichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Department of Surgical Pathology   (Japan)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Alveolar capillary remodeling; Capillary endothelium; Interstitial pneumonia; Nonspecific interstitial pneumonia; Usual interstitial pneumonia

Indexed keywords

MESSENGER RNA; THROMBOMODULIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADULT; APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS WALL; MALE; MICRODISSECTION; THREE DIMENSIONAL IMAGING;

ANTIGENS; APOPTOSIS; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY ALVEOLI; RNA, MESSENGER; THROMBOMODULIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33747640586     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.73.203     Document Type: Article

References (23)

1. The ERS Executive Committee, 2002. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias: This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors. Am J Respir Crit Care Med 2002; 165: 277-304.
2. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV: Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12: 1010-1019.
3. Ebina M, Shimizukawa M, Shibata N, et al.: Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004; 169: 1203-1208.
4. Chambers RC: Role of coagulation cascade proteases in lung repair and fibrosis. Eur Respir J Suppl 2003; 44: 33s-35s.
5. Yasui H, Gabazza EC, Tamaki S, et al.: Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 2001; 163: 1660-1668.
6. Shimizu S, Gabazza EC, Taguchi O, et al.: Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med 2003; 167: 1416-1426.
7. Ludwicka-Bradley A, Bogatkevich G, Silver RM: Thrombin-mediated cellular events in pulmonary fibrosis associated with systemic sclerosis (scleroderma). Clin Exp Rheumatol 2004; 22: S38-S46.
8. Kawanami O, Jin E, Ghazizadeh M, et al.: Mosaic-like distribution of endothelial cell antigens in capillaries and juxta-alveolar micro vessels in the normal human lung. Pathol Int 2000; 50: 136-141.
9. Calnek DS, Grinnell BW: Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor. Exp Cell Res 1998; 238: 294-298.
10. Esmon CT: The protein C pathway. Chest 2003; 124: S26-S32.
11. Terada Y, Eguchi Y, Nosaka S, Toba T, Nakamura T, Shimizu Y: Capillary endothelial thrombomodulin expression and fibrin deposition in rats with continuous and bolus lipopolysaccharide administration. Lab Invest 2003; 83: 1165-1173.
12. Jin E, Fujiwara M, Nagashima M, et al.: Aerogenous spread of primary lung adenocarcinoma induces ultrastructural remodeling of the alveolar capillary endothelium. Hum Pathol 2001; 32: 1050-1058.
13. Jin E, Ghazizadeh M, Fujiwara M, et al.: Angiogenesis and phenotypic alteration of alveolar capillary endothelium in areas of neoplastic cell spread in primary lung adenocarcinoma. Pathol Int 2001; 51: 691-700.
14. Jin E, Fujiwara M, Pan X, et al.: Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer 2003; 97: 703-710.
15. Kawanami O, Jiang HX, Mochimaru H, et al.: Alveolar fibrosis and capillary alteration in experimental pulmonary silicosis in rats. Am J Respir Crit Care Med 1995; 151: 1946-1955.
16. Conway EM, Rosenberg RD: Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988; 8: 5588-5592.
17. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU: Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130.
18. Kawanami O, Matsuda K, Yoneyama H, Ferrans VJ, Crystal RG: Endothelial fenestration of the alveolar capillaries in interstitial fibrotic lung diseases. Acta Pathol Jpn 1992; 42: 177-184.
19. Kuwano K, Miyazaki H, Hagimoto N, et al.: The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 1999; 20: 53-60.
20. Kuwano K, Hagimoto N, Maeyama T, et al.: Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab Invest 2002; 82: 1695-1706.
21. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163: 737-744.
22. Tang K, Rossiter HB, Wagner PD, Breen EC: Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004; 97: 1559-1566.
23. Kanazawa H, Hirata K, Yoshikawa J: Imbalance between vascular endothelial growth factor and endostatin in emphysema. Eur Respir J 2003; 22: 609-612.